DC Field | Value | Language |
---|---|---|
dc.contributor.author | Y H Han | - |
dc.contributor.author | Jung Hun Kwon | - |
dc.contributor.author | Dae Yeul Yu | - |
dc.contributor.author | E Y Moon | - |
dc.date.accessioned | 2017-04-19T09:05:20Z | - |
dc.date.available | 2017-04-19T09:05:20Z | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 1071-5762 | - |
dc.identifier.uri | 10.1080/10715760600868552 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/7606 | - |
dc.description.abstract | Intracellular reactive oxygen species (ROS) were attenuated by the expression of peroxiredoxin II (Prx II). Cellular senescence as judged by senescence-associated (SA)-β-galactosidase (Gal) positive cell formation was increased in Prx II-deficient mouse embryonic fibroblast (MEF). Ras expression was increased following passages. The level of Ras expression was higher in Prx II-/- MEF than wild type MEF. ERK activity was also augmented by the deletion of Prx II. SA-β-Gal-positive cell formation was reduced by PD98059, ERK inhibitor. Activated nuclear transcription factor, nuclear factor-kappaB (NFκB) by the deletion of Prx II was inhibited by the treatment with PD98059. In contrast, no changes in SA-β-Gal-positive cell formation were detected by NFκB inhibitor, N-alpha-tosyl-l-phenylalanyl chloromethyl ketone (TPCK). Collectively, results suggest that Prx II deletion activate Ras-ERK-NFκB pathways and cellular senescence in Prx II-/- MEF cells was mediated by ERK activation but not by NFκB activation. | - |
dc.publisher | T&F (Taylor & Francis) | - |
dc.title | Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFκB pathway in mouse embryonic fibroblast (MEF) senescence | - |
dc.title.alternative | Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence | - |
dc.type | Article | - |
dc.citation.title | Free Radical Research | - |
dc.citation.number | 11 | - |
dc.citation.endPage | 1189 | - |
dc.citation.startPage | 1182 | - |
dc.citation.volume | 40 | - |
dc.contributor.affiliatedAuthor | Dae Yeul Yu | - |
dc.contributor.alternativeName | Han | - |
dc.contributor.alternativeName | 권정훈 | - |
dc.contributor.alternativeName | 유대열 | - |
dc.contributor.alternativeName | 문은이 | - |
dc.identifier.bibliographicCitation | Free Radical Research, vol. 40, no. 11, pp. 1182-1189 | - |
dc.identifier.doi | 10.1080/10715760600868552 | - |
dc.subject.keyword | ERK | - |
dc.subject.keyword | MEF | - |
dc.subject.keyword | NFκB | - |
dc.subject.keyword | Peroxiredoxin II | - |
dc.subject.keyword | Ras | - |
dc.subject.keyword | ROS | - |
dc.subject.local | ERK | - |
dc.subject.local | Erk | - |
dc.subject.local | MEFs | - |
dc.subject.local | MEF | - |
dc.subject.local | Nuclear factor-kappa B | - |
dc.subject.local | nuclear factor κB | - |
dc.subject.local | Nf-κb | - |
dc.subject.local | NF-kB | - |
dc.subject.local | nuclear factor kappa B | - |
dc.subject.local | NF-κB (nuclear factor kappa-B) | - |
dc.subject.local | NF-kappaB | - |
dc.subject.local | Nuclear factor-κb | - |
dc.subject.local | NF-κ B | - |
dc.subject.local | NF-κB | - |
dc.subject.local | NF-kappa B | - |
dc.subject.local | Nuclear factor κB (NF-κB) | - |
dc.subject.local | Nuclear factor κB | - |
dc.subject.local | NFκB | - |
dc.subject.local | Nf-κB | - |
dc.subject.local | Nuclear factor-κB | - |
dc.subject.local | nuclear factorκB | - |
dc.subject.local | Nuclear factor (NF)-κB | - |
dc.subject.local | Nuclear factor kappa B | - |
dc.subject.local | nuclear factor-κB | - |
dc.subject.local | NF-ΚB | - |
dc.subject.local | Nuclear factor-kappa B (NF-κB) | - |
dc.subject.local | Nuclear factor-kappaB | - |
dc.subject.local | nuclear factor-kappaB | - |
dc.subject.local | nuclear factor-kappaB (NF-κB) | - |
dc.subject.local | NFkappaB | - |
dc.subject.local | Nuclear factor kappaB | - |
dc.subject.local | peroxiredoxin II | - |
dc.subject.local | Peroxiredoxin 2 | - |
dc.subject.local | Peroxiredoxin-II | - |
dc.subject.local | peroxiredoxin 2 | - |
dc.subject.local | peroxiredoxin II (Prx II) | - |
dc.subject.local | Peroxiredoxin II | - |
dc.subject.local | Peroxiredoxin2 | - |
dc.subject.local | RAS | - |
dc.subject.local | Ras | - |
dc.subject.local | ras | - |
dc.subject.local | Reactive oxidative species | - |
dc.subject.local | Reactive oxygen species(ROS) | - |
dc.subject.local | Reactive oxygen species | - |
dc.subject.local | Reactive Oxygen Species (ROS) | - |
dc.subject.local | Reactive Oxygen Species | - |
dc.subject.local | ROS | - |
dc.subject.local | Reactive oxygen species (ROS) | - |
dc.subject.local | reactive oxygen species | - |
dc.subject.local | reactive oxygen species (ROS) | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.